NFKB1 and hepatocellular carcinoma: HCC with high NF‐κB activity has uncontrolled inflammation accompanied by aggressive pathologic features and has poor treatment outcomes, whereas blockade of the NF‐κB pathway suppresses proliferation, demonstrating the essential role of NF‐κB activity inhibition in preventing HCC progression.8